CAS 149647-78-9
:Vorinostat
Descripción:
Vorinostat, también conocido por su nombre químico ácido hidroxámico suberoylanilida (SAHA), es un inhibidor de la histona desacetilasa (HDAC) utilizado principalmente en la terapia del cáncer. Se clasifica como un agente antineoplásico y es particularmente efectivo en el tratamiento del linfoma cutáneo de células T (CTCL). Vorinostat actúa alterando la expresión de genes involucrados en la regulación del ciclo celular y la apoptosis, lo que lleva a la inducción de la diferenciación celular y la muerte en células cancerosas. El compuesto se caracteriza por su grupo funcional ácido hidroxámico, que es crucial para su actividad inhibidora de HDAC. Vorinostat se administra típicamente por vía oral y es conocido por sus efectos secundarios, que pueden incluir fatiga, trastornos gastrointestinales y cambios hematológicos. Su farmacocinética implica un metabolismo extenso, principalmente en el hígado, y tiene una vida media relativamente corta. El desarrollo de Vorinostat marcó un avance significativo en la terapia epigenética, destacando el potencial de dirigir modificaciones de histonas en el tratamiento del cáncer.
Fórmula:C14H20N2O3
InChI:InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)
Clave InChI:InChIKey=WAEXFXRVDQXREF-UHFFFAOYSA-N
SMILES:N(C(CCCCCCC(NO)=O)=O)C1=CC=CC=C1
Sinónimos:- Ccris 8456
- M344
- N-Hydroxy-N'-phenyloctanediamide
- N-Hyrdroxy-N'-phenyloctanediamide
- N<sup>1</sup>-Hydroxy-N<sup>8</sup>-phenyloctanediamide
- Octanediamide, N-hydroxy-N'-phenyl-
- Octanediamide, N<sup>1</sup>-hydroxy-N<sup>8</sup>-phenyl-
- SAHA cpd
- Suberanilohydroxamic acid
- Suberoyl anilide bishydroxamide
- Suberoylanilide Hydroxamic Acid
- Unii-58Ifb293Ji
- Vorinostat [USAN]
- Wt 171
- Zolinza
- Octanediamide, N1-hydroxy-N8-phenyl-
- SAHA
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 15 productos.
N-Hydroxy-N'-phenyloctanediamide
CAS:Fórmula:C14H20N2O3Pureza:>98.0%(HPLC)(N)Forma y color:White to Light yellow to Light orange powder to crystalPeso molecular:264.33N-Hydroxy-N'-phenyloctanediamide
CAS:Fórmula:C14H20N2O3Pureza:98%Forma y color:SolidPeso molecular:264.3202Vorinostat
CAS:Vorinostat (SAHA) is a pan-histone deacetylase (HDAC) inhibitor (IC50=10 nM) with inhibitory activity against HDAC1/2/3/6/7/11.Fórmula:C14H20N2O3Pureza:99.47% - 99.65%Forma y color:White Crystalline SolidPeso molecular:264.32N-Hydroxy-N'-Phenyloctanediamide
CAS:N-Hydroxy-N'-PhenyloctanediamidePureza:99%Peso molecular:264.32g/molVorinostat
CAS:Fórmula:C14H20N2O3Pureza:≥ 98.0%Forma y color:White to off-white powderPeso molecular:264.32Suberoylanilide Hydroxamic Acid
CAS:Producto controladoFórmula:C14H20N2O3Forma y color:White SolidPeso molecular:264.32Vorinostat
CAS:<p>M06303 - Vorinostat</p>Fórmula:C14H20N2O3Pureza:97%Forma y color:SolidPeso molecular:264.325Vorinostat
CAS:<p>Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It targets histones and non-histone proteins within transcription factor complexes involved in regulation of cell proliferation (p53), protein stability (Hsp90), apoptosis (Bcl-2 family), cell motility (α-tublin), and angiogenesis (HIF-1α). Vorinostat affects epigenetic regulation in various cancers and has been used in clinical trials as anticancer drug.</p>Fórmula:C14H20N2O3Pureza:Min. 98 Area-%Forma y color:White PowderPeso molecular:264.32 g/molVorinostat - Bio-X ™
CAS:<p>Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It is used to treat cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. This drug inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II).</p>Fórmula:C14H20N2O3Pureza:Min. 99 Area-%Forma y color:PowderPeso molecular:264.32 g/molSuberoylanilide Hydroxamic Acid-13C6
CAS:Producto controlado<p>Applications is the labeled form of Suberoylanilide Hydroxamic Acid (S688700), which is a potent, selective, cell permeable histone deacetylase inhibitor (HDAC), displays anti-angiogenic activity by interfering with VEGF signaling in human umbilical vein endothelial cells (HUVECs) and induces differentiation in human breast cancer cells. Also it is a potent histone deacetylase inhibitor.<br>References Richon, V.M., et al.: Proc. Natl. Acad.Sci. USA, 95, 3003 (1988), Munster, P.N., et al.: Cancer Res., 61, 8492 (2001), Deroanne, C.F., et al.: Oncogene, 21, 247 (2002)<br></p>Fórmula:C6C8H20N2O3Forma y color:NeatPeso molecular:270.276









